Feasibility and Accuracy of Noninvasive Continuous Arterial Pressure Monitoring during Transcatheter Atrial Fibrillation Ablation.

ClearSight arterial pressure atrial fibrillation ablation blood pressure noninvasive continuous arterial pressure monitoring

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
20 Mar 2023
Historique:
received: 24 01 2023
revised: 12 03 2023
accepted: 15 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Transcatheter atrial fibrillation (AF) ablation is still carried out with continuous invasive radial arterial blood pressure (IBP) monitoring in many centers. Continuous noninvasive blood pressure (CNBP) measurement using the volume-clamp method is a noninvasive alternative method used in ICU. No data on CNBP reliability are available in the electrophysiology lab during AF ablation, where rhythm variations are common. The objective of the present study was to compare continuous noninvasive arterial pressure measured with the ClearSight device (Edwards Lifesciences, Irvine, CA, USA) with invasive radial artery pressure used as the reference method during AF ablation. We prospectively enrolled 55 consecutive patients (age 62 ± 11 years, 80% male) undergoing transcatheter AF ablation (62% paroxysmal, 38% persistent) at our center. Standard of care IBP monitoring via a radial cannula and a contralateral noninvasive finger volume-clamp CNBP measurement device were positioned simultaneously in all patients for the entire procedure. Bland-Altman analysis was used to analyze the agreement between the two techniques. A total of 1219 paired measurements for systolic, diastolic, and mean arterial pressure were obtained in 55 subjects, with a mean (SD) of 22 (9) measurements per patient. The mean bias (SD) was -12.97 (13.89) mmHg for systolic pressure (level of agreement -14.24-40.20; correlation coefficient 0.84), -1.85 (8.52) mmHg for diastolic pressure (level of agreement -18.54-14.84; correlation coefficient 0.77) and 2.31 (8.75) mmHg for mean pressure (level of agreement -14.84-19.46; correlation coefficient 0.85). In patients undergoing AF ablation, CNBP monitoring with the ClearSight device showed acceptable agreement with IBP monitoring. Larger studies are needed to confirm the potential clinical implications of continuous noninvasive BP monitoring during AF ablation.

Sections du résumé

INTRODUCTION BACKGROUND
Transcatheter atrial fibrillation (AF) ablation is still carried out with continuous invasive radial arterial blood pressure (IBP) monitoring in many centers. Continuous noninvasive blood pressure (CNBP) measurement using the volume-clamp method is a noninvasive alternative method used in ICU. No data on CNBP reliability are available in the electrophysiology lab during AF ablation, where rhythm variations are common.
BACKGROUND BACKGROUND
The objective of the present study was to compare continuous noninvasive arterial pressure measured with the ClearSight device (Edwards Lifesciences, Irvine, CA, USA) with invasive radial artery pressure used as the reference method during AF ablation.
METHODS METHODS
We prospectively enrolled 55 consecutive patients (age 62 ± 11 years, 80% male) undergoing transcatheter AF ablation (62% paroxysmal, 38% persistent) at our center. Standard of care IBP monitoring via a radial cannula and a contralateral noninvasive finger volume-clamp CNBP measurement device were positioned simultaneously in all patients for the entire procedure. Bland-Altman analysis was used to analyze the agreement between the two techniques.
RESULTS RESULTS
A total of 1219 paired measurements for systolic, diastolic, and mean arterial pressure were obtained in 55 subjects, with a mean (SD) of 22 (9) measurements per patient. The mean bias (SD) was -12.97 (13.89) mmHg for systolic pressure (level of agreement -14.24-40.20; correlation coefficient 0.84), -1.85 (8.52) mmHg for diastolic pressure (level of agreement -18.54-14.84; correlation coefficient 0.77) and 2.31 (8.75) mmHg for mean pressure (level of agreement -14.84-19.46; correlation coefficient 0.85).
CONCLUSION CONCLUSIONS
In patients undergoing AF ablation, CNBP monitoring with the ClearSight device showed acceptable agreement with IBP monitoring. Larger studies are needed to confirm the potential clinical implications of continuous noninvasive BP monitoring during AF ablation.

Identifiants

pubmed: 36983388
pii: jcm12062388
doi: 10.3390/jcm12062388
pmc: PMC10051367
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Anesth Analg. 2019 Mar;128(3):477-483
pubmed: 30649073
BMC Anesthesiol. 2021 May 18;21(1):152
pubmed: 34006231
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
J Clin Monit Comput. 2022 Oct;36(5):1325-1332
pubmed: 34618291
J Interv Card Electrophysiol. 2022 Sep;64(3):743-749
pubmed: 35182273
J Cardiovasc Electrophysiol. 2018 Jun;29(6):854-860
pubmed: 29570900
J Am Heart Assoc. 2016 Jun 13;5(6):
pubmed: 27412904
J Anesth. 2019 Jun;33(3):364-371
pubmed: 30904953
Intensive Care Med. 1986;12(6):424-8
pubmed: 3794060
J Thorac Cardiovasc Surg. 2014 Jan;147(1):236-41
pubmed: 24183909
Europace. 2018 Jan 1;20(1):e1-e160
pubmed: 29016840
Cardiovasc Res. 1998 Jun;38(3):605-16
pubmed: 9747429
J Interv Card Electrophysiol. 2021 Apr;60(3):477-484
pubmed: 32405889
J Biopharm Stat. 2007;17(4):571-82
pubmed: 17613642
Anesth Analg. 2018 Aug;127(2):408-411
pubmed: 29189276
Ann Card Anaesth. 2021 Jul-Sep;24(3):281-287
pubmed: 34269255
J Geriatr Cardiol. 2017 Sep;14(9):563-568
pubmed: 29144514
J Interv Card Electrophysiol. 2022 Jan 17;:
pubmed: 35037145
BMC Anesthesiol. 2020 Jul 20;20(1):176
pubmed: 32690040
JACC Clin Electrophysiol. 2017 Nov;3(11):1240-1248
pubmed: 29759619
J Hum Hypertens. 2019 Nov;33(11):763-765
pubmed: 31578456
Am J Hypertens. 2022 Feb 1;35(2):164-172
pubmed: 34505631
Chest. 2014 Nov;146(5):1155-1158
pubmed: 25367469
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
J Cardiothorac Vasc Anesth. 2021 Jul;35(7):2026-2033
pubmed: 33549488

Auteurs

Andrea Di Cori (A)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Matteo Parollo (M)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Federico Fiorentini (F)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Salvatore Della Volpe (S)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Lorenzo Mazzocchetti (L)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Valentina Barletta (V)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Luca Segreti (L)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Stefano Viani (S)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Raffaele De Lucia (R)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Luca Paperini (L)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Antonio Canu (A)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Gino Grifoni (G)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Ezio Soldati (E)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Maria Grazia Bongiorni (MG)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Giulio Zucchelli (G)

Second Division of Cardiology, Cardiac-Thoracic and Vascular Department, University Hospital of Pisa, 56126 Pisa, Italy.

Classifications MeSH